Table 1.

Bronchoalveolar Lavage Findings in 12 Patients With HIV Infection and T-Cell Alveolitis

PatientsCell RecoveryLymphocytesAlveolar MacrophagesNeutrophilsEosinophilsCD3 T CellsCD4 T CellsCD8 T Cells
×103%×103%×103%×103%×103%×103%×103%×103
1 (ARC)29735103.965193.100008991.611.08890.6
2 (ARC)36741147.658212.913.60091133.711.488129.4
3 (AIDS)2633284.263165.637.812.69075.60.50.48974.1
4 (AIDS)38940155.660233.4000093144.111.592142.6
5 (AIDS)35036115.663220.513.50095109.20.50.594108.6
6 (AIDS)30733101.365199.526.0009090.911.09090.9
7 (AIDS)94520189.075708.7547.20090170.10.50.990170.1
8 (AIDS)80042336.056448.018.019.096322.513.693312.4
9 (AIDS)2893876.861176.30010.38968.310.78866.8
10 (AIDS)3332582.170231.1412.013.39275.40.50.49174.6
11 (AIDS)41131127.468279.814.014.090114.30.50.689113.3
12 (AIDS)40129116.371284.3000093107.811.293107.8
HIV infected patients (as a group)429.3 ± 214.333.5 ± 6.6135.1 ± 70.964.5 ± 5.6279.0 ± 154.41.5 ± 1.66.6 ± 13.00.3 ± 0.31.01 ± 2.691.4 ± 2.2125.2 ± 68.90.79 ± 0.31.1 ± 0.990.4 ± 2.2123.2 ± 66.7
Controls (n = 5)126.6 ± 16.46.8 ± 3.18.6 ± 3.490.8 ± 6.3114.8 ± 18.80.2 ± 0.40.2 ± 0.40.1 ± 0.40.2 ± 0.287.8 ± 3.17.4 ± 2.957.6 ± 3.25.1 ± 1.930.4 ± 3.52.5 ± 1.0
P .01.001.001.001NSNSNSNSNSNS.001.001.01.001.001
  • Abbreviation: NS, not significant.